
    
      Hepatitis A refers to liver inflammation caused by infection with the hepatitis A virus. HAV
      is is one of the most common hepatitis viruses that can cause hepatitis in China. The data
      from the phase 1, 2 and 3 trials suggested that both inactivated hepatitis A vaccine and live
      attenuated hepatitis A vaccine had a clinically acceptable safety and good immunogenicity for
      healthy Chinese people.
    
  